- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alembic Pharmaceuticals Limited — Updates, 07-04-2026: Press Release
07-04-2026 | 12:24 pm
07-04-2026 | 12:24 pm
Alembic Pharma secures USFDA Final Approval for Dapagliflozin Tablets (5mg & 10mg), a generic to Farxiga. This opens a significant market, estimated at US$10,487 million, with 180 days of shared generic exclusivity, promising a strong revenue opportunity.
No comments yet. Be the first to comment!